Abstract: Although the graphic version of the Alternating Sequences Test which was introduced by Luria exists for years little has been done to standardize it. The aim of the current study was to develop a novel and detailed standardized method of administration and scoring. The study sample included 93 normal control subjects (53 women and 40 men) aged 35.87 ± 12.62 and 127 patients suffering from schizophrenia (54 women and 73 men) aged 34.07 ± 9.83. The psychometric assessment included the Positive and Negative Symptoms Scale the Young Mania Rating Scale, and the Montgomery-Asberg Depression Rating Scale. A scoring method was developed and was based on the frequencies of responses of healthy controls. Cronbach a and test-retest and interrater reliability were very good. Two indices and 6 subscales of the Standardized Graphic Sequence Test were eventually developed. The Standardized Graphic Sequence Test seems to be a reliable, valid, and sensitive to change instrument based on Luria's graphic sequence test. The great advantage of this instrument is the fact that it is paper and pencil, easily administered and little time consuming. Further research is necessary to test its usefulness as a neuropsychologic test.
T he Alternating Sequences Test was introduced by Luria [1] [2] [3] and assesses the ability of the frontal lobes to inhibit inappropriate responses. 4 There is a motor version which demands the patient to make a sequence of hand movements (eg, fist-palm-edge) and a graphic (drawing) version which demands the patient to copy a simple alternation of rectangles and peaks or letters. Impaired patients tend to repeat the same movement or shape and do not alternate with the other member of the pair. Attention and concentration is essential in completing this task; confusional or inattentive patients tend to perform poorly.
Typically this group of tests is useful in the study of frontal lobe patients 5 including patients with schizophrenia, which are believed to manifest a type of hypofrontality. The term hypofrontality refers to a decreased functioning of the frontal lobes. It is believed that dopaminergic hypoactivity in the mesocortical dopaminergic system results in negative symptoms whereas an increased dopaminergic activity in the mesolimbic is believed to be the cause of positive symptoms of schizophrenia. Thus, hypofrontality is supposed to relate to negative symptoms and behavioral disinhibition in these patients, and it is a widely accepted characteristic of schizophrenia although it has never been sufficiently proved.
However, although the graphic version of the test exists for years, and is widely used, little has been done to standardize it. Scoring is based on common errors observed and in this way many details in the performance of patients may be lost, especially when the test is used in psychiatric populations.
Samples showing how patients with schizophrenia perform in this task are shown in Figure 1 .
The aim of the current study was to develop a novel and detailed standardized method of administration and scoring of the Graphic Sequence Test and to preliminary test this method in schizophrenic patients. This new scoring method aims to be reliable, valid, and sensitive to change in response to treatment.
MATERIALS AND METHODS

Study Sample
The study sample included 93 normal control subjects (53 women-56.98% and 40 men-43.02%) aged 35.87 ± 12.62 (range: 18 to 68) and 127 patients suffering from schizophrenia according to DSM-IV-TR (54 women-42.52% and 73 men-57.48%) aged 34.07 ± 9.83 (range: 18 to 66). The only inclusion or exclusion criteria concerned the general somatic health (as shown below). No other specific inclusion or exclusion criteria were used and there is no systematic bias in the whole sample. The patients' sample cannot be considered as being representative of the general schizophrenic population; however, it reflects the properties and qualities of patients with schizophrenia usually seen in the outpatient and inpatient facilities of the psychiatric department of a general hospital. Also the selection of control sample obeyed to the same criteria. The only additional criterion posed for controls was age and sex so as the characteristics of the normal subjects to be similar to those of patients with schizophrenia; in this frame, it can be considered to reflect the general population with similar age and sex.
All subjects were physically healthy with normal clinical and laboratory findings. All control subjects and patients gave informed consent and the protocol received approval by the University's Ethics Committee.
Clinical Diagnosis
The diagnosis was put according to DSM-IV-TR criteria on the basis of a semistructured interview on the basis of the Schedules for Clinical Assessment in Neuropsychiatry version 2.0 (SCAN v 2.0). 6 The normal controls were assessed on the basis of a nonstructured free clinical interview.
The Standardized Graphic Sequence Test Procedure
The Standardized Graphic Sequence Test (SGST) procedure demanded the subject to copy a shape of alternating squares and peaks. The shape includes 8 squares and 8 peaks and is shown in the Appendix. Instead of the usual instructions given to the subjects, who demanded the subject to continue drawing the sequence until the end of the sheet, the SGST instructions ask the subject to draw an identical shape on the same piece of paper. The template shape was printed on the left half of the sheet leaving space for the subject to reproduce it on the right. No time limit was set and no time recording was made.
The assessment included the Random Letter Test for the assessment of attention and vigilance. 5 It includes the following 4 series of letters: LTPEAOAISTDALAA; ANIABFSAMPZEOAD; PAKLATSXTOEABAA; and ZYFMTSAHEOAAPAT. The first and third group include 5 ''A,'' whereas the second and the fourth include 4 ''A.'' The testing demands the patient to hit the desk when the examiner pronounces ''A.'' Errors of omission and commission are recorded. It is expected (and verified in the present study) that the mean number of errors expected from normal controls in this test is around 0.2. Both errors of omission and commission were registered for this test.
The Psychometric Assessment
The psychometric assessment included the Positive and Negative Symptoms Scale (PANSS), 7 the Young Mania Rating Scale (YMRS), 8 and the MontgomeryAsberg Depression Rating Scale (MADRS). 9 
Development of a Scoring Method
The scoring method was developed empirically on the basis of qualitative and quantitative analysis of a large number of tests from normal controls, schizophrenic, bipolar, depressive, and anxiety patients. The scoring method is shown with details in the Appendix. The rational behind this effort was the impression the authors had that by using the traditional qualitative way of assessing the graphic sequence test, a lot of information was lost, and the test was not sensitive enough for use in ''nonorganic'' mental patients. The first step was to create a list of errors, omissions, and other deviations from normal, seen in the testing of the above-mentioned subjects. The second phase led to the development of 13 items and their scoring instructions for field-testing. These 13 items eventually constituted the SGST. The aim was to apply a scoring method solely on the basis of percentiles derived from the normal controls group. The authors did not proceed to try to calculate sensitivity and specificity for one or more specific cut-off points, because the overlapping between groups was significant and the test seems to be useful to assess aspects of cognitive function but not as a specific diagnostic test for a specific illness.
Statistical Analysis
The statistical analysis included the development of frequency tables for scores of healthy controls so as to arrive at percentile scores and develop a scoring method for the scale. The Pearson R correlation coefficient, factor analysis (varimax normalized rotation-correlations among items of the SGST were low enough to permit an orthogonal rotation), and Item Analysis 10 (calculation of Cronbach a) were used to explore the internal structure of the scale. Although a significant number of correlations were calculated, no correction (eg, Bonferroni) was applied, simply because this would lead all correlations to be considered nonsignificant. However, in this frame, correlation analysis should be considered as exploratory. Analysis of variance (ANOVA), 11 was used to test the difference between groups, and was performed separately for subjects below and above the age of 40. Discriminant Function Analysis was also used to explore differences between groups and the power of the scale in discriminating between them. The Pearson R correlation coefficient was calculated to assess the test-retest reliability and the interrater reliability. However, the calculation of correlation coefficients is not a sufficient method to test reliability and reproducibility of a method and its results, because it is an index of correlation and not an index of agreement. [11] [12] [13] The calculation of means and SDs for each SGST item and total score during the first (test) and second (retest) applications may provide an impression of the stability of results over time.
Also, the means and the SDs of the differences concerning each SGST item between test and retest were calculated and the plots of the test versus retest and difference versus average value for each variable were created. In fact, it is not possible to use statistics to define acceptable agreement. 11 However, these plots may assist decision. This method was used in previous studies concerning the validation of scientific methods. 14, 15 
RESULTS
The frequency tables for scores of healthy controls are shown in Table 1 . In the same table the proposed scoring for each item is also shown. This scoring method is based solely on the frequencies of responses of healthy controls (percentiles).
The 1-way ANOVA with diagnostic group as the independent variable and all the SGST items plus SGST total score as dependent variables, performed twice for 2 different age groups (below and over 40 y of age) revealed significant results both for subjects under the age of 40 (df = 14, 152; F = 7.239; P<0.001), and for those above this age (df = 14, 143; F = 6.802; P<0.001). The results are shown in Table 2 along with post hoc tests. It seems that in older subjects the differences tend to minimize because the performance of controls gets worse.
The Pearson R correlation coefficients, among the SGST items in the total study sample are shown in Table 3 .
The Pearson R correlation coefficients, among the SGST items and the Positive, Negative, and General Psychopathology scales (PANNS), the YMRS, and the MADRS are shown in Table 4 .
The correlations among the SGST items were low enough to permit an orthogonal rotation in the factor analysis. The results of the factor analysis (varimax normalized rotation) are shown in Table 5 . The analysis produced 6 factors (by using the Keiser-Fleish criterion of eigenvalues larger than 1) explaining 62% of the total variance. The scores in the subscales created on the basis of these factors and the differences between groups in these scales are also shown in Table 5 . The 1-way ANOVA revealed significant differences between the 2 diagnostic groups concerning the subscales (df = 6.120; F = 10.605; P<0.001). The post hoc t test revealed that the 2 groups differed in all subscales except Close-in (CI) ( Table 5 ).
The correlation coefficients among these subscales are shown in Table 6 . Some correlations among these scales are statistically significant but weak. A second factor analysis of these subscales produced 2 superfactors explaining 24% of total variance each. The first one included subscales 1, 4, and 5 and the second one included subscales 2, 3, and 6 ( Table 7) . Item Analysis (calculation of Cronbach a) Cronbach a=0.41, with no item increasing dramatically the a coefficient when omitted. This leads to the conclusion that the various items assess different aspects of performance and there is a factor structure underlying.
The Discriminant Function Analysis used the diagnostic groups as the grouping variable and all SGST items as the dependent variables. The results are shown in Table 8 . This analysis produced the following function: When À8.222+0.0179Â(SGST-1)+0.0110Â(SGST-6) +0.0192 Â (SGST-9)+0.0189 Â (SGST-11) >0 then the subject is likely to be a normal control rather than a schizophrenic patient. This function classified correctly 73.11% of controls and 79.52% of patients with schizophrenia, which is a satisfactory performance.
The Pearson R correlation coefficient (R) for interrater reliability is 0.80 for the total SGST scale and ranges from 0.61 to 1.00 for individual items and subscales
TABLE 3. Pearson Correlation Coefficients (R) Among the SGST Items and Random Letter Test Scores in the Total Study Sample
RLT-A RLT-B SGST-1 SGST-2 SGST-3 SGST-4 SGST-5 SGST-6 SGST-7 SGST-8 SGST-9 SGST-10 SGST-11 SGST-12 SGST-13 (Table 9) ; concerning test-retest reliability, the same coefficient was equal to 0.54 for the total SGST scale and ranged from À 0.03 to 0.80 for individual items and subscales (Table 9 ). Retest was done within 5 days of first testing. The calculation of means and SDs for each SGST item and total score during the first (test) and second (retest) applications as well as the plots of the test versus retest and difference versus average value for each variable suggested that the SGST is reliable and replicable.
DISCUSSION
Although several decades have passed since the Alternating Sequences Tests were introduced by Luria, [1] [2] [3] little has been done to standardize them. This may be due to the complex pattern of these tests and a preference of the examiners to score them on the basis of an ''overall'' impression or ''qualitatively.'' Specifically concerning the graphic version of the test, which exists for years, and is widely used, little data can be found in the literature. Scoring is based on common errors observed. The problem is that in this way many details in the performance of patients may be lost, and this is especially true when the test is used in psychiatric populations. Luria himself was rather closer to a ''qualitative'' and ''clinical'' interpretation rather than a ''standardized'' and ''quantified'' one. Even the Luria-Nebraska battery uses a very simple way to score these tests.
The current study attempted to develop a standardized scoring method that would allow the examiner to reliably quantify the subject's performance in the Graphic Sequence Test, which is one of the Alternating Sequences Tests. This test demands the subject to copy a simple Total variance explained
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The second order factor loadings which determine the grouping (above 0.4) are marked in bold characters.
drawing. Both the drawing template and the resulting Standardized Graphic Sequence Test along with the scoring method developed by the current study are shown in the Appendix. The test and its scoring method proved to be highly reliable, stable, and sensitive to change after treatment. Sensitivity to change after treatment is evident from examples of how performance on the SGST changes after 2 months antipsychotic treatment, shown in Figure 2 . However, what remains is to apply the test to different patient population, especially to patients suffering from ''organic'' brain disease, before and after therapeutic intervention.
The scoring method is such that allows for maximum contrast and differentiation between normal subjects and patients and simultaneously leaves little space for subjective assessment. The results of the Discriminant Function Analysis support this. However, apart from Discriminant Function Analysis, the authors did not proceed to try to calculate sensitivity and specificity for one or more specific cut-off points, because the overlapping between groups was significant and the test seems to be useful to assess aspects of cognitive function but not as a specific diagnostic test for a specific illness.
The correlation coefficients among individual SGST items although significant, are all below 0.30 suggesting that each item assesses a distinct issue. This is also reflected in factor analysis. The 6 factors that emerge explain roughly 10% of the total variance each. The SGST can be divided into subscales on the basis of the factor analysis and its interpretation. In this way, 6 subscales can be created. The first factor includes items 1, 3, and 4 and largely reflects missing elements. Thus, it may constitute the basis of a subscale named ''Missing Elements'' (ME). The second one includes items 2, 5, and 8 and rather reflects errors in drawing leading to distortions of the shape. Thus, it constitutes the basis of a subscale under the title ''Errors'' (E). The third factor includes items 10 and 11 and reflects differences in size. The resulting subscale is named ''Size'' (S). The fourth factor includes items 3, 9, and 13 and is an index of perseveration, and constitutes the basis of the ''Perseveration'' (P) subscale. The fifth includes items 6 and 7 and represents corrections of the mistakes thus being the basis of the ''Corrections'' (C) subscale. The sixth factor includes items 2 (again) and 12 and similarly reflects closing-in, giving rise to the ''Close-in'' (CI) subscale. Schizophrenic patients differ in all subscales from controls, except the last one. Correlations among these subscales are significant but weak. The factor analysis of these subscales produced 2 superfactors, named ''Indices.'' The first (subscales 1, 4, and 5) constitutes the ''Deficit Index'' (DcI), whereas the second (subscales 2, 3, and 6) is the ''Deformation Index'' (DfI). It is important to note that all the items of the SGST included in the DcI are easy for the normal subject, whereas the more difficult ones (2, 5, and 8) are included in the DfI. Patients differ from controls concerning both indices (P<0.001). In the frame of the above, the SGST is divided into the following 2 indices and 6 subscales: a. DcI that includes the following 3 subscales:
1. Missing Elements (ME) subscale (items 1, 3, and 4). 2. Perseveration subscale (P) (items 3, 9, and 13). 3. Corrections (C) subscale (items 6 and 7). b. DfI that includes the following 3 subscales:
1. Errors (E) subscale (items 2, 5, and 8).
2. Size (S) subscale ((items 10 and 11). 3. CI subscale (items 2 and 12). The correlations among the psychometric scales (PANSS, YMRS, and the MADRS) and individual items and subscales of the SGST revealed some very interesting points (Table 3 ). The PANSS-Positive subscale correlates negatively only with closing-in. The PANSS-Negative subscale correlates negatively with fragmentation and closing-in and positively with lower size for peaks. PANSS-General Psychopathology correlates negatively with fragmentation and closing-in. The YMRS is rather difficult to interpret in schizophrenic patients and in the current study it was used to have a measure to compare with bipolar patients in future studies. The MADRS correlated positively with total missing elements, bigger size of drawing, and negatively with errors. From the above it is obvious that the relationship of schizophrenia and its psychometric profile to the frontal lobe function as assessed by the SGST is rather complex and nonlinear and further research is necessary to uncover specific issues and mechanisms.
The authors believe that future factor analysis with the inclusion of different patient groups will help to further elucidate the mechanism underlying the performance in the SGST. A preliminary suggestion on the basis of the data of the current study (Tables 1, 5) could be that the fragmentation of the drawing is an early sign of disorder followed by closing-in, while intruding elements appear latter in the procedure. However, this remains to be tested and needs further and focused research.
Conclusively, the current study developed a reliable, valid, and sensitive to change instrument for the testing of frontal lobe function based on Luria's graphic sequence test. The great advantage of this instrument is the fact that it is paper and pencil, easily administered and little time consuming. Further research is necessary to test its usefulness as a neuropsychologic test.
(continued) 7 .
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